MMRC drug development projects will speed the development of new therapies for myeloma patients worldwide through integrated and collaborative research efforts. The MMRC conducts cutting-edge research in the most promising areas of multiple myeloma and is especially focused on the development of novel, targeted therapies. This innovative model for rapid drug development will lead to accelerated testing of new, lifesaving therapies, resulting not only in a greater understanding of multiple myeloma, but a faster discovery of a cure for the disease. We believe the MMRC research paradigm could be useful for many other diseases, including various forms of cancer.
